Ellington Management Group’s Amedisys AMED Stock Holding History

Ellington Management Group’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,300	Closed	-$217K	–	527
2019 Q4	$217K	Sell	1,300 -700	-35%	-$104K	0.05%	425
2019 Q3	$262K	Buy	+2,000	New	+$260K	0.05%	415
2019 Q2	–	Sell	-8,800	Closed	-$1.08M	–	568
2019 Q1	$1.08M	Buy	8,800 +6,800	+340%	+$853K	0.2%	122
2018 Q4	$234K	Buy	+2,000	New	+$236K	0.07%	273
2016 Q2	–	Sell	-10,600	Closed	-$512K	–	262
2016 Q1	$512K	Buy	+10,600	New	+$409K	0.22%	129
2015 Q4	–	Sell	-29,709	Closed	-$1.13M	–	576
2015 Q3	$1.13M	Buy	29,709 +15,891	+115%	+$670K	0.32%	56
2015 Q2	$549K	Sell	13,818 -282	-2%	-$8.79K	0.13%	217
2015 Q1	$378K	Buy	+14,100	New	+$398K	0.08%	382
2013 Q4	–	Sell	-14,500	Closed	-$250K	–	556
2013 Q3	$250K	Buy	+14,500	New	+$215K	0.05%	580

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ellington Management Group's AMED Position: Q1 2020 in Review

Ellington Management Group sold out of Amedisys (AMED) in Q1 2020, closing a stake of 1,300 shares — an estimated $217K sold.

Ellington Management Group first reported a position in AMED in Q3 2013 and held it in 9 quarters. The position peaked at $1.13M in Q3 2015. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

Ellington Management Group reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
Ellington Management Group sold 1,300 Amedisys shares in Q1 2020, an estimated $217K.
Ellington Management Group first reported a position in Amedisys in Q3 2013 and held it in 9 quarters.
Ellington Management Group's Amedisys position peaked at $1.13M in Q3 2015.
332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.